Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0886-3350(89)80128-2 | DOI Listing |
Graefes Arch Clin Exp Ophthalmol
September 2024
Faculty of Life Sciences & Medicine, King's College London, London, SE1 7EH, UK.
Purpose: To investigate the antifibrotic and vasoconstrictor effects of adrenaline in Schlemm's canal and suprachoroidal minimally invasive glaucoma surgery (MIGS).
Methods: Human trabecular meshwork (TM) cells were treated with different concentrations of adrenaline (0%, 0.0005%, 0.
J Glaucoma
August 2024
Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, IL.
Can Vet J
February 2024
VCA West Los Angeles Animal Hospital, 1900 South Sepulveda Boulevard, Los Angeles, California 90025, USA (Allen); Department of Companion Animals, Atlantic Veterinary College, University of Prince Edward Island, 550 University Avenue, Charlottetown, Prince Edward Island C1A 4P3 (Côté).
The occurrence of right-sided congestive heart failure (CHF) in dogs with left-sided heart disease is well-recognized, but its mechanisms are incompletely understood. A 12-year-old Maltese dog was admitted to the clinic for left atrial decompression to treat recurrent CHF due to severe myxomatous mitral valve disease (MMVD). Left atrial decompression was successful but atrial fibrillation (AF) occurred during the procedure.
View Article and Find Full Text PDFOcul Immunol Inflamm
October 2024
Centre Universitaire d'Ophtalmologie (CUO) de l'Université de Montréal, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada.
Purpose: To determine the outcomes and predisposing factors of Descemet's membrane endothelial keratoplasty () complicated by intraoperative fibrinous reaction.
Methods: Retrospective cohort study of 346 DMEKs. Medical charts were reviewed for recipient demographics, surgical indications, donor characteristics, and potential predisposing ocular and systemic factors.
J Ocul Pharmacol Ther
July 2023
Department of Ophthalmology, Baylor College of Medicine, Houston, Texas, USA.
Sustained intraocular drug delivery devices are being developed to lower intraocular pressure (IOP) and improve adherence in patients with glaucoma. The purpose of this study was to assess the IOP and eyedrop usage reduction effects of intracameral bimatoprost implants. We retrospectively reviewed the records of 46 eyes from 38 patients who received an intracameral implant containing 10 μg of bimatoprost as a replacement or addition to their existing eyedrop regimen and investigated IOP, eyedrop usage, and adverse effects.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!